Mapping large numbers of results may take a few moments.
Search Results
Showing 251 - 300 of 438 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company Madera Therapeutics LLC | Activity: Research and Development | Company Description Madera Therapeutics is developing small molecule anti-cancer agents that function via activation of the mitochondrial protease, ClpP. Madera's TR Compounds have direct effects on bulk cancer cells and inhibit cancer stem cell function. | Location Cary | |
Company Mammae Biosciences | Activity: Research and Development | Company Description Mammae Biosciences develops enzyme technologies to help food manufacturers produce prebiotic dietary fibers, including oligosaccharides. | Location Raleigh | |
Company MARBIONC Development Group LLC | Activity: Research and Development | Company Description MARBIONC Development Group is a nonprofit organization that develops and markets new products and technologies derived from marine and aquatic organisms. | Location Wilmington | |
Company Marius Pharmaceuticals LLC | Activity: Research and Development | Company Description Marius Pharmaceuticals develops therapeutic treatments, with a focus on oral testosterone replacement therapies for adult men symptomatic of hypogonadism. | Location Raleigh | |
Company Mastezellen Bio Inc. | Activity: Research and Development | Company Description Mastezellen Bio is developing therapeutics for the treatment of diseases and disorders with mast cell involvement. | Location Research Triangle Park | |
Company Mazen Animal Health (RTP) | Activity: Research and Development | Company Description Mazen Animal Health develops, delivers and commercializes orally-delivered biological vaccines and therapeutics for animals using recombinant DNA. | Location Durham | |
Company MDxHealth Inc. | Activity: Research and Development | Company Description MDxHealth develops epigenetic technologies to personalize the diagnosis and treatment of cancer. | Location Hillsborough | |
Company MED-EL Corporation USA | Activity: Research and Development | Company Description Med-El researches and develops cochlear implant technology. The Durham location manufactures cochlear implants and is also the North American headquarters. | Location Durham | |
Company Merakris Therapeutics Inc. | Activity: Research and Development | Company Description Merakris Therapeutics develops biotherapeutic technologies derived from stem cells that promote homeostasis in damaged tissue. | Location Research Triangle Park | |
Company Merlon Inc. | Activity: Research and Development | Company Description Merlon develops small-molecule inhibitors for treatment of BRAF-mutated cancers resistant to BRAF and MEK inhibitors. | Location Durham | |
Company Merz Aesthetics | Activity: Research and Development | Company Description Merz Aesthetics develops injectables, devices and skincare products. | Location Raleigh | |
Company Merz Therapeutics | Activity: Research and Development | Company Description Merz Therapeutics develops and commercializes neurological therapeutic treatment solutions for patients who suffer from movement disorders and neurological health conditions. | Location Raleigh | |
Company Microscale Devices LLC | Activity: Research and Development | Company Description Microscale Devices is developing an advanced optic system for genotyping fluorophores. | Location Morrisville | |
Company MIDAS Biotech LLC | Activity: Research and Development | Company Description MIDAS Biotech develops in vitro diagnostic products. | Location Morrisville | |
Company Midnight Pharma LLC | Activity: Research and Development | Company Description Midnight Pharma is developing a treatment for insomnia. | Location Morrisville | |
Company Mind Medicine Inc. | Activity: Research and Development | Company Description Mind Medicine is a clinical-stage biopharmaceutical company developing products using the therapeutic potential of psychedelics to treat brain health disorders, with a focus on psychiatry, addiction, pain and neurology. | Location Durham | |
Company Mintrition Technologies LLC | Activity: Research and Development | Company Description Mintrition Technologies is developing a technology to encapsulate a mineral form of zinc in cellulose that can be added to animal feed to promote gut health. | Location Apex | |
Company MitoRainbow Therapeutics Inc. | Activity: Research and Development | Company Description MitoRainbow is developing treatments for TK2 deficiency, a mitochondrial disease that manifests as severe myopathy. | Location Cary | |
Company Mizar Therapeutics | Activity: Research and Development | Company Description Mizar Therapeutics is a platform therapeutics company that provides drug discovery services using proprietary live-cell single-molecule imaging and machine-learning technology. | Location Chapel Hill | |
Company Mosaic Biosciences | Activity: Research and Development | Company Description Mosaic Biosciences develops new soil health solutions and provides advanced crop nutrition, specializing in plant innate immunity, plant physiology and nutrient use efficiency. | Location Durham | |
Company Mucommune LLC | Activity: Research and Development | Company Description Mucommune is developing a platform using monoclonal antibodies and mucus to reinforce the mucus barrier for female reproductive health. | Location Durham | |
Company MultiSeq Inc. | Activity: Research and Development | Company Description MultiSeq out-licenses molecular diagnostics platform technologies for cancer and infectious disease diagnosis. | Location Greensboro | |
Company Mycologics | Activity: Research and Development | Company Description Mycologics develops green antimicrobials to safeguard food, feed, and health from harmful fungal pathogens and their toxins (mycotoxins). | Location Durham | |
Company Mycorrhiza Biotech LLC | Activity: Research and Development | Company Description Mycorrhiza Biotech develops products and services to improve plant production. They specialize in fungi and allied organisms for diverse applications in agri-business. | Location Burlington | |
Company Mycosynthetix Inc. | Activity: Research and Development | Company Description Mycosynthetix manages a large collection of fungal isolates and discovers novel fungal metabolites for human and animal health and compounds for agricultural applications. | Location Hillsborough | |
Company Mycovia Pharmaceuticals Inc. | Activity: Research and Development | Company Description Mycovia Pharmaceuticals is developing therapies to treat yeast and fungal infections. | Location Durham | |
Company Myodenovo | Activity: Research and Development | Company Description Myodenovo is developing cultivated meat products. | Location Durham | |
Company NabGen Inc. | Activity: Research and Development | Company Description NabGen has developed a universal antibody suppressant technology to inhibit anti-drug and autoimmune antibodies, including suppression of pre-existing immunity and re-administration barriers to gene therapies based on adeno-associated virus (AAV) vectors. | Location Durham | |
Company Natures Crops International | Activity: Research and Development | Company Description Natures Crops supplies plant-derived ingredients from biodiverse and specialty crops to the dietary supplement, personal care and specialty nutrition industries. | Location Winston-Salem | |
Company Nelum Corp. | Activity: Research and Development | Company Description Nelum is a clinical-stage biopharmaceutical company developing patented drugs through an in-license process. Nelum´s focus is in oncology and fibrotic indications. | Location Cary | |
Company NeuroGT Inc. | Activity: Research and Development | Company Description NeuroGT is developing gene therapy products to treat rare neurogenetic diseases. | Location Chapel Hill | |
Company New Hope Biodiagnostics LLC | Activity: Research and Development | Company Description New Hope Biodiagnostics is developing biodiagnostics for cancer. | Location Chapel Hill | |
Company Nicox Ophthalmics | Activity: Research and Development | Company Description Nicox Ophthalmics develops therapeutics from a proprietary nitric-oxide research platform to help maintain vision and improve ocular health. | Location Durham | |
Company NIRvana Sciences Inc. | Activity: Research and Development | Company Description NIRvana Sciences is commercializing red and near-infrared fluorescent dyes for use in diagnostics and imaging applications. | Location Research Triangle Park | |
Company Nova Thin Film Pharmaceuticals LLC | Activity: Research and Development | Company Description Nova Thin Film Pharmaceuticals develops and manufactures dissolving thin film using patented DepoFilm technology to solve drug delivery challenges. | Location Greensboro | |
Company NovaCyte LLC | Activity: Research and Development | Company Description NovaCyte isolates cells from donor corneas to grow replacement corneal tissue on a scaffold as a bioengineered equivalent to the current standard of care. | Location Winston-Salem | |
Company Novonesis BioAg | Activity: Research and Development | Company Description Novonesis BioAg develops microbial-based biofertility, biocontrol and bioyield enhancer products for agriculture. The Morrisville site focuses on fermentation and production technology. | Location Morrisville | |
Company Nufarm Americas Inc. | Activity: Research and Development | Company Description Nufarm manufactures and markets insecticides, fungicides, plant growth regulators and herbicides. This site serves as Nufarm's primary research and development facility in the United States. | Location Morrisville | |
Company NuPulseCV | Activity: Research and Development | Company Description NuPulseCV is developing an implantable cardiovascular left ventricular assist device to treat people suffering from congestive heart failure. | Location Raleigh | |
Company NuRevelation LLC | Activity: Research and Development | Company Description NuRevelation develops drug delivery methods for pharmaceuticals, nutraceuticals and cannabinoids. | Location Durham | |
Company Ocaro Pharmaceuticals | Activity: Research and Development | Company Description Ocaro Pharmaceuticals develops opioid-sparing pain medications. | Location Greensboro | |
Company Oerth Bio LLC | Activity: Research and Development | Company Description Oerth Bio is supporting crop protection, crop health, and healthy food by leveraging PROTAC® protein degrades, which work by harnessing the plant's own natural protein disposal system to degrade and remove unwanted proteins. | Location Durham | |
Company Om Bharti LLC | Activity: Research and Development | Company Description Om Bharti is developing a machine-learning software product that will integrate and analyze large sets of biological data to provide actionable outputs that expedite research, development, industrialization, and optimization. | Location Wilmington | |
Company On.Target Molecules Biotech Inc. | Activity: Research and Development | Company Description O.TM Biotech is developing anti-cancer monoclonal antibodies using a novel technology platform to accelerate advancements in cancer therapeutics. | Location Wilmington | |
Company Oncotect | Activity: Research and Development | Company Description Oncotect is a chemical and biomolecular diagnostic company developing technology for the early detection of cancer in dogs. | Location Raleigh | |
Company Oncurie Inc. | Activity: Research and Development | Company Description Oncurie is developing a cure for metastatic cancer through the use of novel molecular radionuclide technology. | Location Raleigh | |
Company OnSite Remediation LLC | Activity: Research and Development | Company Description OnSite Remediation develops and uses naturally-occurring microbes, mechanical separators, coalescing units and filtration systems for the removal of contaminants from water and soil. | Location Cary | |
Company Optera LLC | Activity: Research and Development | Company Description Optera is developing a technology to improve honey bee Varroa-mite resistance. | Location Greensboro | |
Company Opus Genetics Inc. | Activity: Research and Development | Company Description Opus Genetics is a clinical-stage gene therapy company developing treatments for inherited retinal diseases. | Location Research Triangle Park | |
Company Osmotica Pharmaceutical Corp. | Activity: Research and Development | Company Description Osmotica Pharmaceutical specializes in drug-delivery technologies and neurology-based therapies, including a treatment for Parkinson's disease. | Location Wilmington |